Comparison of AI software tools for automated detection, quantification and categorization of pulmonary nodules in the HANSE LCS trial

Author:

Kondrashova Rimma1,Klimeš Filip1,Kaireit Till Frederik1,May Katharina2,Barkhausen Jörg2,Stiebeler Susanne3,Sperl Jonathan4,Dettmer Sabine1,Wacker Frank1,Vogel-Claussen Jens1

Affiliation:

1. Hannover Medical School

2. University Hospital Schleswig-Holstein

3. Hospital Grosshansdorf

4. MR Application Predevelopment, Siemens Healthcare GmbH

Abstract

Abstract Purpose To compare the performance of two AI-based software tools for detection, quantification and categorization of pulmonary nodules in a lung cancer screening (LCS) program in Northern Germany (HANSE-trial). Method 946 low-dose baseline CT-examinations were analyzed by two AI software tools regarding lung nodule detection, quantification and categorization and compared to the final radiologist read. The relationship between detected nodule volumes by both software tools was assessed by Pearson correlation (r) and tested for significance using Wilcoxon signed-rank test. The consistency of Lung-RADS classifications was evaluated by Cohen’s kappa (κ) and percentual agreement (PA). Results 1032 (88%) and 782 (66%) of all (n = 1174, solid, semi-solid and ground-glass) lung nodules (volume ≥ 34mm3) were detected by Software tool 1 (S1) and Software tool 2 (S2), respectively. Although, the derived volumes of true positive nodules were strongly correlated (r > 0.95), the volume derived by S2 was significantly higher than by S1 (P < 0.0001, mean difference: 6mm3). Moderate PA (62%) between S1 and S2 was found in the assignment of Lung-RADS classification (κ = 0.45). The PA of Lung-RADS classification to final read was 75% and 55% for S1 and S2. Conclusion Participant management depends on the assigned Lung Imaging Reporting and Data System (Lung-RADS) category, which is based on reliable detection and volumetry of pulmonary nodules. Significant nodule volume differences between AI software tools lead to different Lung-RADS scores in 38% of cases, which may result in altered participant management. Therefore, high performance and agreement of accredited AI software tools are necessary for a future national LCS program.

Publisher

Research Square Platform LLC

Reference32 articles.

1. Schwartz Ann G.and Cote ML. Epidemiology of Lung Cancer. In: Ahmad Aamirand Gadgeel S, ed. Lung Cancer and Personalized Medicine: Current Knowledge and Therapies. Cham: Springer International Publishing; 2016:21–41.

2. Cancer statistics, 2023;Siegel RL;CA Cancer J Clin,2023

3. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening;Smith RA;CA Cancer J Clin,2018

4. The National Lung Screening Trial: Overview and Study Design 1 National Lung Screening Trial Research Team. Radiology, 2011.

5. NELSON lung cancer screening study;Zhao YR;Cancer Imaging,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3